Market Overview
The Europe Hospital Acquired Infections Diagnostics Market is valued at USD 1.52 billion in 2025, with projections to reach approximately USD 1.61 billion by 2030 at a 1.2% CAGR. This figure represents a specialized segment within the broader European infectious disease diagnostics market, which encompasses a wider range of testing categories. Official government statistical agencies do not publish isolated revenue figures for this specific subsegment, meaning market size estimates rely on commercial research methodologies rather than official national health statistics.
- •Market valued at USD 1.52 billion in 2025
- •Projected to reach USD 1.61 billion by 2030 at 1.2% CAGR
- •Data relies on commercial estimates, not official government figures
- •Part of the broader European infection control market worth USD 14.99 billion in 2025
Growth Drivers
The modest 1.2% CAGR reflects several competing factors within European healthcare systems. On one hand, the persistent prevalence of healthcare-associated infections and increasing regulatory emphasis on infection prevention protocols create steady demand for diagnostic solutions. On the other hand, the growth rate is restrained by healthcare budget constraints, cost-containment measures, and the maturity of certain testing markets across Western European nations.
- •Ongoing regulatory pressure for infection surveillance and reporting
- •Aging patient populations requiring more complex care
- •Healthcare budget constraints limiting rapid market expansion
- •Growing emphasis on antimicrobial stewardship programs
Segmentation and Regional Analysis
The market encompasses various diagnostic technologies and infection types, with common targets including bloodstream infections, surgical site infections, pneumonia, and urinary tract infections acquired in healthcare settings. Western Europe, including Germany, France, and the United Kingdom, represents the largest regional segment due to advanced healthcare infrastructure and stringent regulatory frameworks. Eastern European markets are gradually expanding as healthcare systems modernize their infection control capabilities.
- •Key infection categories: bloodstream, surgical site, respiratory, and urinary tract infections
- •Western Europe dominates the market due to advanced infrastructure
- •Eastern Europe showing gradual growth with healthcare modernization
- •Molecular diagnostics and rapid testing methods gaining adoption
Trends and Outlook
What are the recent trends and outlook?
Looking forward, the market is expected to maintain steady but modest growth as European healthcare systems balance infection control imperatives with economic constraints. Molecular diagnostic technologies, including PCR-based and next-generation sequencing approaches, are anticipated to gain share over traditional culture-based methods. The broader infectious disease diagnostics market in Europe is projected to grow at 8.4% CAGR, suggesting hospital-acquired infection diagnostics may underperform relative to adjacent segments focused on emerging pathogens and point-of-care testing solutions.
- •Molecular and nucleic acid amplification tests expected to gain market share
- •Point-of-care testing gaining importance for faster clinical decisions
- •Integration with digital health platforms and electronic medical records increasing
- •Antimicrobial resistance surveillance driving demand for advanced diagnostics
Get in touch and our analysts will be happy to help with custom market sizing, deeper segmentation, supplier detail or a bespoke study built for you.
Connect to an analyst →Market size and forecast are Claight Analysis, informed by public research and industry data. Historical years before 2025 and all forecast years are Claight estimates at the stated CAGR. Retrieved 2026.